Competing in the age of telemedicine
Waivers for telemedicine are likely to be extended — offering hospitals and health systems a window of opportunity to defend against competition from pure-play telemedicine providers. In MedCity News, Duane Fitch discusses where to focus first.
It’s no secret that telemedicine usage has skyrocketed since the onset of the COVID-19 public health emergency, primarily due to convenience, access, and waivers on Medicare limitations. Now, if the signals cast by the Centers for Medicare and Medicaid Services’ proposed 2023 Medicare Physician Fee Schedule (PFS) rule come true, the waivers will carry into 2023. This extension offers hospitals and health systems a small window of opportunity to establish a well-rounded and far-reaching strategic plan that incorporates telemedicine. One that will bring efficiency to their organizations, defend against emerging competition from pure-play telemedicine providers, and ensure their place in providing all elements of care to the populations they serve. 
